MCID: LRN003
MIFTS: 49

Learning Disability

Categories: Mental diseases, Neuronal diseases

Aliases & Classifications for Learning Disability

MalaCards integrated aliases for Learning Disability:

Name: Learning Disability 12 15
Learning Disabilities 53 29 6 42 43 15 71
Learning Disorders 54 71
Academic Skill Disorder 12
Learning Disorder 12

Classifications:



External Ids:

Disease Ontology 12 DOID:8927
MeSH 43 D007859
NCIt 49 C89334
ICD10 32 F81.9
UMLS 71 C0023186 C0751265

Summaries for Learning Disability

MedlinePlus : 42 What is a learning disability? Learning disabilities are conditions that affect the ability to learn. They can cause problems with Understanding what people are saying Speaking Reading Writing Doing math Paying attention Often, children have more than one kind of learning disability. They may also have another condition, such as attention deficit hyperactivity disorder (ADHD), which can make learning even more of a challenge. What causes learning disabilities? Learning disabilities don't have anything to do with intelligence. They are caused by differences in the brain, and they affect the way the brain processes information. These differences are usually present at birth. But there are certain factors that can play a role in the development of a learning disability, including Genetics Environmental exposures (such as lead) Problems during pregnancy (such as the mother's drug use) How do I know if my child has a learning disability? The earlier you can find and treat a learning disability, the better. Unfortunately, learning disabilities are usually not recognized until a child is in school. If you notice that your child is struggling, talk to your child's teacher or health care provider about an evaluation for a learning disability. The evaluation may include a medical exam, a discussion of family history, and intellectual and school performance testing. What are the treatments for learning disabilities? The most common treatment for learning disabilities is special education. A teacher or other learning specialist can help your child learn skills by building on strengths and finding ways to make up for weaknesses. Educators may try special teaching methods, make changes to the classroom, or use technologies that can assist your child's learning needs. Some children also get help from tutors or speech or language therapists. A child with a learning disability may struggle with low self-esteem, frustration, and other problems. Mental health professionals can help your child understand these feelings, develop coping tools, and build healthy relationships. If your child has another condition such as ADHD, he or she will need treatment for that condition as well. NIH: National Institute of Child Health and Human Development

MalaCards based summary : Learning Disability, also known as learning disabilities, is related to specific learning disability and prader-willi syndrome. An important gene associated with Learning Disability is FIBP (FGF1 Intracellular Binding Protein), and among its related pathways/superpathways are Neuroscience and MAP Kinase Signaling. The drugs Aripiprazole and Sodium citrate have been mentioned in the context of this disorder. Affiliated tissues include brain, testes and eye, and related phenotypes are behavior/neurological and growth/size/body region

Disease Ontology : 12 A specific developmental disorder that involves difficulty in scholastic skills such as reading, writing, spelling, reasoning, recalling and/or organizing information resulting from the brain's inability to receive and process information.

NINDS : 53 Learning disabilities are disorders that affect the ability to understand or use spoken or written language, do mathematical calculations, coordinate movements, or direct attention. Although learning disabilities occur in very young children, the disorders are usually not recognized until the child reaches school age. Research shows that 8 to 10 percent of American children under 18 years of age have some type of learning disability.

Wikipedia : 74 Learning disability, learning disorder or learning difficulty (British English) is a condition in the... more...

Related Diseases for Learning Disability

Diseases related to Learning Disability via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 476)
# Related Disease Score Top Affiliating Genes
1 specific learning disability 34.3 SYNE2 RPS6KA3 PTPN11 NF1 IQSEC2 CACNA1A
2 prader-willi syndrome 32.0 PRODH MECP2 FMR1 CFAP47
3 specific developmental disorder 31.6 PRODH MECP2 MAPT FMR1 CFAP47
4 alacrima, achalasia, and mental retardation syndrome 31.1 PURA MECP2 IQSEC2 FMR1 CACNA1A
5 disease of mental health 30.9 PRODH MECP2 MAPT FMR1
6 epilepsy 30.8 PURA PRODH PLPBP MECP2 MAPT CACNA1A
7 autism 30.5 TBL1XR1 PRODH NF1 MECP2 MAPT IQSEC2
8 speech disorder 30.5 PRODH MAPT FMR1
9 autism spectrum disorder 30.5 PRODH NF1 MECP2 IQSEC2 FMR1 CDH8
10 west syndrome 30.4 TBL1XR1 MECP2 IQSEC2 CACNA1A
11 epileptic encephalopathy, early infantile, 6 30.2 MECP2 IQSEC2 CACNA1A
12 tremor 30.1 MAPT FMR1 CACNA1A
13 pervasive developmental disorder 30.1 PRODH MECP2 FMR1 CDH8
14 heart septal defect 30.0 PTPN11 PRODH CFAP47
15 atrial heart septal defect 29.9 PTPN11 PRODH CFAP47
16 chromosomal deletion syndrome 29.7 PRODH MECP2 FMR1
17 epilepsy, x-linked, with variable learning disabilities and behavior disorders 12.7
18 shprintzen omphalocele syndrome 12.2
19 sotos syndrome 1 12.0
20 giacheti syndrome 11.7
21 feingold syndrome 1 11.6
22 dysgraphia 11.6
23 fragile x syndrome 11.5
24 neurofibromatosis, type i 11.5
25 grange syndrome 11.5
26 turner syndrome 11.5
27 dyslexia 11.5
28 47,xyy 11.5
29 digeorge syndrome 11.4
30 velocardiofacial syndrome 11.4
31 dyscalculia 11.4
32 speech and communication disorders 11.4
33 down syndrome 11.3
34 reading disorder 11.3
35 writing disorder 11.3
36 saethre-chotzen syndrome 11.3
37 neural tube defects 11.3
38 dandy-walker syndrome 11.3
39 histidinemia 11.3
40 thauvin-robinet-faivre syndrome 11.3
41 fetal alcohol syndrome 11.3
42 cerebellar hypoplasia 11.3
43 legius syndrome 11.3
44 myopathy with extrapyramidal signs 11.2
45 silver-russell syndrome 1 11.1
46 microphthalmia, syndromic 3 11.1
47 bloom syndrome 11.1
48 robin sequence with cleft mandible and limb anomalies 11.1
49 osteopathia striata with cranial sclerosis 11.1
50 shukla-vernon syndrome 11.1

Graphical network of the top 20 diseases related to Learning Disability:



Diseases related to Learning Disability

Symptoms & Phenotypes for Learning Disability

MGI Mouse Phenotypes related to Learning Disability:

45
# Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 10.28 BBIP1 CACNA1A CDH8 FMR1 IQSEC2 MAPT
2 growth/size/body region MP:0005378 10.25 BBIP1 CACNA1A FMR1 IQSEC2 MAPT MECP2
3 homeostasis/metabolism MP:0005376 10.15 CACNA1A COLEC11 MAPT MECP2 MYCN NF1
4 integument MP:0010771 10.06 CACNA1A CDH8 FMR1 MAPT MECP2 NF1
5 nervous system MP:0003631 10.03 BBIP1 CACNA1A CDH8 FMR1 IQSEC2 MAPT
6 muscle MP:0005369 9.8 CACNA1A MAPT MYCN NF1 PTPN11 RPS6KA3
7 respiratory system MP:0005388 9.61 CACNA1A MECP2 MYCN NF1 NPAS3 PTPN11
8 vision/eye MP:0005391 9.36 BBIP1 CACNA1A CDH8 FMR1 MAPT MECP2

Drugs & Therapeutics for Learning Disability

Drugs for Learning Disability (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 137)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Aripiprazole Approved, Investigational Phase 4 129722-12-9 60795
2
Sodium citrate Approved, Investigational Phase 4 68-04-2
3
Caffeine Approved Phase 4 58-08-2 2519
4
Acetylcysteine Approved, Investigational Phase 4 616-91-1 12035
5
Dopamine Approved Phase 4 51-61-6, 62-31-7 681
6
Methylphenidate Approved, Investigational Phase 4 113-45-1 4158
7
Clavulanate Approved, Vet_approved Phase 4 58001-44-8 5280980
8
Amoxicillin Approved, Vet_approved Phase 4 26787-78-0 33613
9
Testosterone enanthate Approved Phase 4 315-37-7 9416
10
Testosterone Approved, Experimental, Investigational Phase 4 58-22-0, 481-30-1 10204 6013
11
Testosterone undecanoate Approved, Investigational Phase 4 5949-44-0
12
Methyltestosterone Approved Phase 4 58-18-4 6010
13
Amphetamine Approved, Illicit, Investigational Phase 4 300-62-9 5826 3007
14
Guanfacine Approved, Investigational Phase 4 29110-47-2 3519
15
Citric acid Approved, Nutraceutical, Vet_approved Phase 4 77-92-9 311
16
Folic acid Approved, Nutraceutical, Vet_approved Phase 4 59-30-3 6037
17 Dopamine Antagonists Phase 4
18 Antipsychotic Agents Phase 4
19 Psychotropic Drugs Phase 4
20 Dopamine agonists Phase 4
21 Antidepressive Agents Phase 4
22 Serotonin 5-HT1 Receptor Agonists Phase 4
23 Serotonin Receptor Agonists Phase 4
24 Citrate Phase 4
25 Phosphodiesterase Inhibitors Phase 4
26 Caffeine citrate Phase 4
27 Trace Elements Phase 4
28 Micronutrients Phase 4
29 Respiratory System Agents Phase 4
30 Vitamins Phase 4
31 Anti-Infective Agents Phase 4
32 Antidotes Phase 4
33 Vitamin B Complex Phase 4
34 Expectorants Phase 4
35 Antiviral Agents Phase 4
36 Antioxidants Phase 4
37 Folate Phase 4
38 Protective Agents Phase 4
39 Nutrients Phase 4
40 Omega 3 Fatty Acid Phase 4
41 N-monoacetylcystine Phase 4
42 Vitamin B9 Phase 4
43 Dopamine Agents Phase 4
44 Central Nervous System Stimulants Phase 4
45 Anti-Bacterial Agents Phase 4
46 Hormones Phase 4
47 Amoxicillin-Potassium Clavulanate Combination Phase 4
48 beta-Lactamase Inhibitors Phase 4
49 Antibiotics, Antitubercular Phase 4
50 Antineoplastic Agents, Hormonal Phase 4

Interventional clinical trials:

(show top 50) (show all 189)
# Name Status NCT ID Phase Drugs
1 Methylphenidate in Healthy Young Adults Unknown status NCT00815841 Phase 4 METHYLPHENIDATE
2 Aripiprazole Treatment for Antipsychotic Induced Hyperprolactinaemia in Patients With Severe Mental Illness and Learning Disabilities Completed NCT01085383 Phase 4 Aripiprazole
3 Magnetic Resonance Imaging and Neurodevelopmental Outcomes in Preterm Infants Following Administration of High-Dose Caffeine - A Pilot Study Completed NCT00809055 Phase 4 Caffeine citrate
4 Language-based Learning Skills and ADHD: Impact of Treatment With Sustained-release Guanfacine Completed NCT01146002 Phase 4 Guanfacine (sustained release)
5 An Open-Label Clinical Trial Conducted Via Telepsychiatry of Complementary and Alternative Treatments (Omega-3 Fatty Acids and Inositol vs. N-acetylcysteine) for the Management of Emotional Dysregulation in Youth With Non-verbal Learning Disability (NVLD) and/or Autism Spectrum Disorders (ASD) Recruiting NCT03757585 Phase 4 Open-label Treatment with Omega-3 Fatty Acids + Inositol;Open-label Treatment with N-acetylcysteine
6 An Oral Amoxicillin-Clavulanate Regimen to Prevent Bacteremia Following Recruiting NCT02783404 Phase 4 Amoxicillin;Amoxicillin-Potassium Clavulanate
7 TESTO: Testosterone Effects on Short-Term Outcomes in Infants With XXY Recruiting NCT03325647 Phase 4 Testosterone Cypionate 200 Milligram/Milliliter Injectable Solution;Placebo injectable saline
8 Adaptive Response to Intervention (RTI) for Students With ADHD Recruiting NCT03511976 Phase 4 Stimulant
9 Dose Clinical Trial of Guanfacine Extended Release for the Reduction of Aggression and Self-injuries Behavior Associated With Prader-Willi Syndrome Not yet recruiting NCT04066088 Phase 4 Guanfacine extended release (GXR)
10 Enhancing Self-Understanding and Social Integration of Middle School Students With Learning Disabilities Unknown status NCT00246792 Phase 2, Phase 3
11 Efficacy of RAD001/Everolimus in Autism and NeuroPsychological Deficits in Children With Tuberous Sclerosis Complex Unknown status NCT01730209 Phase 2, Phase 3 Everolimus;Placebo
12 Prospective Trial of Risperdal (Risperidone) Following Psychological Therapy for Challenging Behaviour in Learning Disabled Children Completed NCT00254930 Phase 3 risperidone
13 Effects of Vertical Prism on the Symptoms of Dizziness, Headache and Anxiety as Caused by Vertical Heterophoria: A Randomized, Double-blinded, Placebo-controlled, Cross-over Study Completed NCT00785135 Phase 3
14 Infant Heart Surgery: Central Nervous System Sequelae of Circulatory Arrest Completed NCT00000470 Phase 3
15 Multicenter Double-blind Placebo-Controlled Randomized Clinical Trial of Efficacy and Safety of Tenoten for Children in the Treatment of Specific Developmental Disorders of Scholastic Skills in Children Completed NCT03159104 Phase 3 Tenoten for children;Placebo
16 Memantine for the Treatment of Social Deficits in Youth With Disorders of Impaired Social Interactions: A Randomized-controlled Trial Recruiting NCT03553875 Phase 3 Memantine Hydrochloride;Placebo
17 Dexmedetomidine Sedation Versus General Anaesthesia for Inguinal Hernia Surgery on Peri-operative Outcomes and Neurocognitive Development in Infants: A Randomized Controlled Trial Recruiting NCT02559102 Phase 3 Dexmedetomidine sedation;General sevoflurane anaesthesia
18 Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants - a Randomized, Double-blind, Placebo-controlled, Prospective, and Multicenter Clinical Study Active, not recruiting NCT02076373 Phase 3 recombinant human Erythropoietin;Placebo
19 Isoflurane-induced Neuroinflammation in Children With Hydrocephalus: A Bench-to-bedside, Translational Study of Molecular Pathways and Therapeutic Approaches Terminated NCT02512809 Phase 3 Isoflurane;Dexmedetomidine
20 Preterm Fetal Growth Restriction and Developmental Care Unknown status NCT00166660 Phase 2
21 Building Complex Language: Effect of Treatment and Dosage Completed NCT01337232 Phase 1, Phase 2
22 A Randomized, Double-blind, Placebo-controlled, Dose-ranging Study of the Safety and Pharmacokinetics of Oral NNZ-2566 in Pediatric Rett Syndrome Completed NCT02715115 Phase 2 NNZ-2566;Placebo
23 A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Escalation Study of NNZ-2566 in Rett Syndrome Completed NCT01703533 Phase 2 NNZ-2566;Placebo
24 Placebo Controlled Trial of Dextromethorphan in Rett Syndrome Completed NCT01520363 Phase 2 dextromethorphan;placebo
25 Investigation of Simvastatin Therapy in Smith-Lemli-Opitz Syndrome Completed NCT00064792 Phase 2 Simvastatin Susp.;OraPlus
26 Erythropoetin Neuroprotection for Neonatal Cardiac Surgery Completed NCT00513240 Phase 1, Phase 2 Erythropoetin;Normal saline
27 Neurobiology and Treatment of Reading Disability in NF1 Recruiting NCT02964884 Phase 2 Lovastatin;Placebo Oral Tablet
28 A Randomized, Double-blind, Placebo-controlled, 2-period Crossover Study of BPN14770 in Adult Males With Fragile X Syndrome Active, not recruiting NCT03569631 Phase 2 BPN14770;Placebo
29 Working Memory Training in Attention-Deficit/Hyperactivity Disorder: Neural Mechanisms of Change Unknown status NCT01657721 Phase 1
30 Trial to Evaluate the Safety of Lovastatin in Individuals With Neurofibromatosis Type I (NF1) Completed NCT00352599 Phase 1 Lovastatin;Lovastatin;placebo pill
31 VidRT: Video Distraction During Radiation Therapy to Decrease Use of Pediatric Sedation Completed NCT03677531 Phase 1
32 The Contribution of Risk and Resilience Factors in Learning Disabilities Population to Academic and Emotional Development Unknown status NCT01652651
33 Efficacy and Safety of Memantine Hydrochloride, a Low Affinity Antagonist to N-Methyl-D-Aspartate (NMDA) Type Receptors, in the Prevention of Cognitive Decline and Disease Progression in Down’s Syndrome Unknown status NCT00240760 Memantine Hydrochloride
34 The Additive Effect of Cognitive Behavioral Treatment - CBT to Conventional Weight Loss Intervention Program for Young Adults With Intellectual Disabilities Unknown status NCT01032369
35 Topiramate Treatment for Patients With Epilepsy and Learning Disability : A Prospective Observational Study Unknown status NCT00956696 topiramate
36 Teacher Help: Novel Technologies for Meeting the Immediate Needs of Youth With Mental Health Disorders in Canada Unknown status NCT02919215
37 Working Memory Training in College Students With ADHD/LD Unknown status NCT01154686
38 Study of the Neurofibromatosis 1 Expression: Identification of the Modifying Genes Unknown status NCT01650142
39 Development of a New Diagnosis and Intervention Method for Developmental Disorders Unknown status NCT01166152
40 Epidemiological Study for Psychiatric Disorder Among Children and Adolescents Unknown status NCT02707848
41 Investigating the Effects of an Added Parent Component to Cognitive Behavior Therapy for Youth With Anxiety Disorders Unknown status NCT02160444
42 Identification and Comprehension of Focused Stress in a Sentence Among Adults Who Suffered Traumatic Brain Injury Unknown status NCT02499133
43 Efficacy of External Cold and a Vibrating Device in Reducing Discomfort of Dental Injections in Children - A Split Mouth Randomized Clinical Trial Unknown status NCT02675387 2%Lidocaine
44 Dialectical Behavioral Therapy (DBT) Based Skills Group for Children With Emotional Dysregulation and Their Parents Unknown status NCT01299740
45 Individual Schema-mode Therapy for Anorexia Nervosa: a Pilot Case Series Unknown status NCT02666495
46 A Pilot Randomized Controlled Trial to Test Effectiveness of the ACE4 (Activity Challenge - 4 Areas) for Depression and Anxiety: A Behavioural Activation Based Game. Unknown status NCT02538549
47 Randomized Control Trial of RESOLVE (Relaxation Exercise, SOLving Problem and cognitiVe Errors): A Waiting Room Intervention for Crisis Clients Unknown status NCT02536924
48 Is a Primer Needed for Orthodontic Bonding? A Multi-centre RCT Unknown status NCT01782521
49 Using New Genetic Technology to Diagnose Neurodevelopmental Disorders Completed NCT02227381
50 Investigation of Lycra Splinting Garments for Falls and Intellectual Disabilities Completed NCT02345512

Search NIH Clinical Center for Learning Disability

Cochrane evidence based reviews: learning disabilities

Genetic Tests for Learning Disability

Genetic tests related to Learning Disability:

# Genetic test Affiliating Genes
1 Learning Disabilities 29

Anatomical Context for Learning Disability

MalaCards organs/tissues related to Learning Disability:

40
Brain, Testes, Eye, Heart, Thyroid, Cortex, Temporal Lobe

Publications for Learning Disability

Articles related to Learning Disability:

(show top 50) (show all 7812)
# Title Authors PMID Year
1
Towards a South African model of language-based learning disability. 61 42
31793312 2019
2
Specific Learning Disabilities: The Family Physician's Role. 42 61
31730315 2019
3
Saliva cortisol, melatonin levels and circadian rhythm alterations in Chinese primary school children with dyslexia. 42
32028434 2020
4
Using Video-Based Instruction via Augmented Reality to Teach Mathematics to Middle School Students With Learning Disabilities. 61
32065040 2020
5
The Occurrence of FUS Mutations in Pediatric Amyotrophic Lateral Sclerosis: A Case Report and Review of the Literature. 61
32281455 2020
6
Evaluation of Multidisciplinary Team Clinic for Patients With Isolated Cleft Lip. 61
31961207 2020
7
Asthma phenotypes and associated comorbidities in a large cohort of adolescents in Israel. 61
31017024 2020
8
Do Children Classified With Specific Language Impairment Have a Learning Disability in Writing? A Meta-Analysis. 61
32396037 2020
9
Further delineation of the female phenotype with KDM5C disease causing variants: 19 new individuals and review of the literature. 61
32279304 2020
10
Premorbid estimates of neuropsychological functioning for diverse groups. 61
30773042 2020
11
The impact and challenges of the 2018 MHRA statement on the use of sodium valproate in women of childbearing age during the first year of implementation, in a UK epilepsy centre. 61
32380376 2020
12
The relevance of subtyping children with mathematical learning disabilities. 61
32574935 2020
13
Impaired School Functioning in Children with Chronic Pain: A National Perspective. 61
32487871 2020
14
The health of college students on the autism spectrum as compared to their neurotypical peers. 61
32551992 2020
15
Characteristics and Prevalence of Gravitational Insecurity in Children with Sensory Processing Dysfunction. 61
32247101 2020
16
Estimated Prevalence of Asthma in US Children With Developmental Disabilities. 61
32543699 2020
17
Weighing up the risks and benefits of community gambling venues as recreational spaces for people with lifelong disability. 61
32532245 2020
18
Screening for intellectual disability in Dutch psychiatrically disturbed detainees: Assessing the psychometric properties of the Screener for Intelligence and Learning Disability (SCIL). 61
32578391 2020
19
Estimating local need for mental healthcare to inform fair resource allocation in the NHS in England: cross-sectional analysis of national administrative data linked at person level. 61
31391127 2020
20
A new 1p36.13-1p36.12 microdeletion syndrome characterized by learning disability, behavioral abnormalities, and ptosis. 61
32170730 2020
21
Pediatric Migraine and Academics. 61
32529391 2020
22
The Role of Sphenobasilar Synchondrosis in Disease and Health. 61
32451540 2020
23
Neuron-specific knockdown of solute carrier protein SLC25A46a induces locomotive defects, an abnormal neuron terminal morphology, learning disability, and shortened lifespan. 61
32140609 2020
24
A Systematic Review of Academic Discourse Interventions for School-Aged Children With Language-Related Learning Disabilities. 61
32525756 2020
25
Reading-writing disorder in children with idiopathic epilepsy. 61
32563891 2020
26
Peer Support in Mental Health: Literature Review. 61
32357127 2020
27
Newborn screening for galactosaemia. 61
32567677 2020
28
Investigation on participation, supports and barriers of children with specific learning disabilities. 61
32259721 2020
29
"It's probably nothing, but…" Couples' experiences of pregnancy following an uncertain prenatal genetic result. 61
31955407 2020
30
The Lecture Note-Taking Skills of Adolescents With and Without Learning Disabilities. 61
31904315 2020
31
The disproportionately high prevalence of learning disabilities amongst adults attending Saint Marys Sexual Assault Referral Centre. 61
32064726 2020
32
A comparison of local-global visuospatial processing in autism spectrum disorder, nonverbal learning disability, ADHD and typical development. 61
32442872 2020
33
The influence of mindfulness meditation on inattention and physiological markers of stress on students with learning disabilities and/or attention deficit hyperactivity disorder. 61
32163834 2020
34
The 15q11.2 BP1-BP2 Microdeletion (Burnside-Butler) Syndrome: In Silico Analyses of the Four Coding Genes Reveal Functional Associations with Neurodevelopmental Phenotypes. 61
32384786 2020
35
Improving mental health in autistic young adults: a qualitative study exploring help-seeking barriers in UK primary care. 61
32312761 2020
36
Sex, race, ADHD, and prior concussions as predictors of concussion recovery in adolescents. 61
32200661 2020
37
Suprachiasmatic lesions restore object recognition in down syndrome model mice. 61
32195448 2020
38
Biopsychosocial factors associated with depression and anxiety in older adults with intellectual disability: results of the wave 3 Intellectual Disability Supplement to The Irish Longitudinal Study on Ageing. 61
32215976 2020
39
The impact of an adult intellectual disability screening questionnaire on service providers and users. 61
31746057 2020
40
Systematic CHAAOS: Teaching Vocabulary in English/Language Arts Special Education Classes in Middle School. 61
32462963 2020
41
Mediating the interface between voluntariness and coercion: A qualitative study of learning disability nurses' work in medical examinations of people with intellectual disability. 61
32043689 2020
42
Brivaracetam efficacy and tolerability in clinical practice: A UK-based retrospective multicenter service evaluation. 61
32179501 2020
43
Assessing Dyslexia at Six Year of Age. 61
32421001 2020
44
Skill Profiles of College Students With a History of Developmental Language Disorder and Developmental Dyslexia. 61
32028829 2020
45
Preservice educators' and noneducators' knowledge and perceptions of responsibility about dyslexia. 61
31994258 2020
46
Summer-born struggle: The effect of school starting age on health, education, and work. 61
32052533 2020
47
Automated video-based detection of nocturnal motor seizures in children. 61
32378204 2020
48
16p13.11 microduplication in 45 new patients: refined clinical significance and genotype-phenotype correlations. 61
30287593 2020
49
5-aminolevulinic acid inhibits oxidative stress and ameliorates autistic-like behaviors in prenatal valproic acid-exposed rats. 61
31991146 2020
50
Uncovering the Process of Reasonable Academic Accommodations for Prelicensure Nursing Students With Learning Disabilities. 61
32384368 2020

Variations for Learning Disability

ClinVar genetic disease variations for Learning Disability:

6 ‎‎
# Gene Name Type Significance ClinVarId dbSNP ID GRCh37 Pos GRCh38 Pos
1 FIBP NM_004214.5(FIBP):c.652C>T (p.Gln218Ter)SNV Pathogenic/Likely pathogenic 189359 rs786204849 11:65652652-65652652 11:65885181-65885181

Expression for Learning Disability

Search GEO for disease gene expression data for Learning Disability.

Pathways for Learning Disability

Pathways related to Learning Disability according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.56 NF1 MYCN MECP2 MAPT FMR1
2 11.18 RPS6KA3 PTPN11 NF1

GO Terms for Learning Disability

Cellular components related to Learning Disability according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 postsynapse GO:0098794 9.33 PURA MECP2 FMR1
2 dendrite GO:0030425 9.02 PURA NF1 MAPT FMR1 CACNA1A
3 glial cell projection GO:0097386 8.96 MAPT FMR1

Molecular functions related to Learning Disability according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 siRNA binding GO:0035197 8.62 MECP2 FMR1

Sources for Learning Disability

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....